Investigational New Drug (IND) Studies | Preclinical Development | Charles River

investigational new drug (IND) 

During the preclinical stage of drug development, timelines are critical for the filing of an Investigational New Drug (IND) application within a predetermined timeframe and budget. Evolving market pressures have changed the focus of the drug development industry, accelerating early phases further in order to create late-stage pipeline growth. Given these increasing pressures, understanding how and when to plan your preclinical IND-enabling program is an integral part of meeting specific milestones leading to on-time IND submission.

Learn through our years of experience, unique range of services and best-in-class expertise how we are best suited to help you successfully initiate and complete your IND-enabling program. With our ongoing efforts to improve upon our internal processes and continued focus on scientific excellence and guidance, we are pleased to announce the most cost-effective IND program for our clients.

For your IND guide and full access to our accelerated reporting timelines, including a full-size Gantt chart, please log in to The Source. If you are not a member of The Source, our new online scientific and educational information center, please click here to register.

Gantt chart

Related Information
Webinar Replay – Planning and Understanding Your IND Program (January 2012)

For more information about our preclinical capabilities, contact us at askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

+44 (0) 1875 614545
askcharlesriver@crl.com

view all

News & Events

view all
mai 14 - New Models for Evaluating COPD or ...
mai 11 - Expert Safety Testing to Accelerat...
juin 14-juin 14 - Hørsholm, Denmark - Biotech Outsourcing Strategies (chemistry, manufa...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA, US

Charles River Laboratories, Inc.